POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,526,657 | -23.5% | 3,527,235 | +3.9% | 0.00% | -50.0% |
| Q2 2023 | $30,769,137 | +35.6% | 3,396,152 | +8.8% | 0.00% | +100.0% |
| Q1 2023 | $22,692,542 | -63.7% | 3,121,395 | -63.6% | 0.00% | -50.0% |
| Q4 2022 | $62,493,628 | +168.7% | 8,572,514 | +184.9% | 0.00% | +100.0% |
| Q3 2022 | $23,261,000 | +54.0% | 3,009,168 | +35.7% | 0.00% | 0.0% |
| Q2 2022 | $15,103,000 | +602.1% | 2,217,796 | +721.6% | 0.00% | – |
| Q1 2022 | $2,151,000 | +52.0% | 269,937 | +6.8% | 0.00% | – |
| Q4 2021 | $1,415,000 | -18.7% | 252,692 | +11.6% | 0.00% | – |
| Q3 2021 | $1,741,000 | – | 226,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
| Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
| BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
| JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
| PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
| Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
| Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
| Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |